Abstract
Synthesis of a racemic 4′-ethynyl-2′-deoxyribose intermediate using stereoselective chelation control is presented. This intermediate is further transformed to 4′-ethynyl-2′-deoxy- and 4′-ethynyl-2′,3′-dideoxy-2′,3′-didehydronucleoside analogues.
Key words
HIV - nucleosides - stereoselective synthesis - carbohydrates - chelation control
References
1a
Fisch MA.
AIDS
1999,
13 (Suppl.1):
S49
1b
Mitsuya H.
Erickson J. In
Textbook of AIDS Medicine
Merigan TC.
Bartlet JG.
Bolognesi D.
Lippincott Williams & Wilkins;
Baltimore:
1999.
p.751
2 Parikh, U.; Koontz, D.; Sluis-Cremer, N.; Hammond, J.; Bacheler, L.; Schinazi, R.; Mellors, J. 11
th
Annual Conference on Retroviruses and Opportunistic Infections ; San Francisco, CA, February 8-11, 2004 ; Paper #54.
3
Agarwal RPA.
Olivero O.
Mutat. Res.
1997,
390:
223
4a
Summerer D.
Marx A.
Bioorg. Med. Chem. Lett.
2005,
15:
869
4b
Dutchman GE.
Grill SP.
Gullen EA.
Haraguchi K.
Takeda S.
Tanaka H.
Baba M.
Cheng Y.-C.
Antimicrob. Agents Chemother.
2004,
48:
1640
4c
Kodama E.-I.
Kohgo S.
Kitano K.
Machida H.
Gatanaga H.
Shigeta S.
Matsuoka M.
Ohrui H.
Mitsuya H.
Antimicrob. Agents Chemother.
2001,
45:
1539
5a
Secrist JA.
Winter WJA.
J. Am. Chem. Soc.
1978,
100:
2554
5b
Youssefyeh RD.
Verheyden PH.
Moffat JG.
J. Org. Chem.
1979,
44:
1301
5c
Haraguchi K.
Tanaka H.
Miyasaka T.
Tetrahedron Lett.
1990,
31:
227
5d
Haraguchi K.
Tanaka H.
Itoh Y.
Saito S.
Miyasaka T.
J. Org. Chem.
1992,
33:
2841
5e
Johnson CR.
Esker JL.
Van Zandt MC.
J. Org. Chem
1994,
59:
5854
5f
Haraguchi K.
Tanaka H.
Itoh Y.
Yamaguchi K.
Miyasaka T.
J. Org. Chem.
1996,
61:
851
5g
Marx A.
Erdmann P.
Senn M.
Korner S.
Jungo T.
Petretta M.
Imwinkelried P.
Dussy A.
Kulicke KJ.
Macko L.
Zehnder M.
Tiese B.
Helv. Chim. Acta
1996,
79:
1980
5h
Shuto S.
Knanzaki M.
Ichikawa S.
Matsuda A.
J. Org. Chem.
1997,
62:
5676
5i
Shuto S.
Knanzaki M.
Ichikawa S.
Minakawa N.
Matsuda A.
J. Org. Chem.
1998,
63:
746
Compound 1 :
5j
Sugimoto I.
Shuto S.
Mori S.
Shigeta S.
Matsuda A.
Bioorg. Med. Chem. Lett.
1999,
9:
385
Compound 2 :
5k
Haraguchi K.
Takeda S.
Tanaka H.
Nitanda T.
Baba M.
Dutschman GE.
Cheng Y.-C.
Bioorg. Med. Chem. Lett.
2003,
13:
3775
5l
Haraguchi K.
Takada S.
Tanaka H.
Org. Lett.
2003,
5:
1399
5m
Haraguchi K.
Itoh Y.
Takeda S.
Honma Y.
Tanaka H.
Nitanda T.
Baba MD.
Dutschman GE.
Cheng Y.-C.
Nucleosides, Nucleotides Nucleic Acids
2004,
23:
647
Compound 3 :
5n
Ohrui H.
Kohgo S.
Kitano K.
Sakata S.
Kodama E.
Yoshimura K.
Matsuoka M.
Shigeta S.
Mitsuya H.
J. Med. Chem.
2000,
43:
4516
6a
Marco JA.
Carda M.
Gonzalez F.
Rodriguez S.
Castillo E.
Murga J.
J. Org. Chem.
1998,
63:
698
6b This reference explains the observed syn addition of ethynylmagnesium bromide by an α-chelate where the oxygen atom alpha to the ketone forms a 5-ring chelate as shown in Figure
[2 ]
. Ether protecting groups other than MOM are expected to afford good chelation control since the authors in reference 6 report 91:9 syn -selectivity using ethynylmagnesium chloride and a ketone substrate having α-OBn in place of MOM and TBDPS in place of TBDMS.
7 For another nucleoside example of building functionality into an acyclic intermediate followed by ring-closure, see: Zhu W.
Chong Y.
Choo H.
Mathews J.
Schinazi R.
Chu CK.
J. Med. Chem.
2004,
47:
1631
8
Vorbruggen H.
Ruh-Pohlenz C. In
Handbook of Nucleoside Synthesis
Wiley;
New York:
2001.
p.15
9
Duschinsky R.
Gabriel T.
Hoffer M.
Berger J.
Titsworth E.
Grunberg E.
Burchenal JH.
Fox JJ.
J. Med. Chem.
1966,
9:
566
10a
Tan C.-H.
Stork T.
Feeder N.
Holmes AB.
Tetrahedron Lett.
1999,
40:
1397
10b
Song J.
Hollingsworth RI.
Tetrahedron: Asymmetry
2001,
12:
387